Quarterly report pursuant to Section 13 or 15(d)

Equity Compensation Plan (Details Narrative)

v3.21.2
Equity Compensation Plan (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 9 Months Ended
Mar. 11, 2020
Jun. 22, 2021
Sep. 22, 2020
Jul. 16, 2020
Mar. 26, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 30, 2021
Sep. 30, 2020
Sep. 25, 2021
Sep. 22, 2021
Sep. 16, 2020
Sep. 15, 2020
Jun. 18, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Stock-based compensation expense           $ 221,000 $ 180,000 $ 1,123,000 $ 329,000          
General and administrative expenses           192,000 101,000 1,023,000 198,000          
Research and development expenses           27,000 36,000 69,000 70,000          
Cost of revenues           2,000 $ 43,000 31,000 $ 61,000          
Unamortized stock-based compensation           1,300,000   $ 1,300,000            
Unamortized stock-based compensation period               1 year 8 months 12 days            
Intrinsic value of outstanding           547,000   $ 547,000            
Intrinsic value of vested stock options           $ 413,000   $ 413,000            
Chief Executive Officer [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Unvested options                   25,000 1,911,160      
Options Held [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Option grant term   10 years                        
Option granted   388,246                        
Equity Compensation Plan description The grant was reduced to 500,000 options, including 375,000 options and 125,000 options respectively under the two categories, due to limitations under the 2019 Plan. The terms of the 125,000 performance based options were established in the quarter ended September 30, 2020. The terms of the performance based options were met during the quarter ended March 31, 2021.       Board of Directors and a majority of the Company’s shareholders approved an amendment to the 2019 Plan to (i) increase the number of shares of common stock authorized for issuance under the 2019 Plan by 1,174,000 shares, such that a total of 2,500,000 shares of common stock are now authorized for issuance under the 2019 Plan; (ii) increase the maximum aggregate number of shares, options and/or other awards that may be granted to any one person during any calendar year from 500,000 to 1,300,000; and (iii) clarify the availability of cashless exercise as a form of consideration.                  
Options Held [Member] | Minimum [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Option exercise price   $ 2.90                        
Options Held [Member] | Maximum [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Option exercise price   $ 3.93                        
Options Held [Member] | Executive Chairman [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Option grant term 10 years     10 years                    
Option granted 965,850     600,000                    
Option exercise price       $ 1.50                    
Options Held [Member] | Chief Executive Officer [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Option grant term     10 years                      
Option granted 321,950   1,637,410 200,000                    
Option exercise price     $ 1.50                      
N 2019 Equity Compensation Plan [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Number of Shares Authorized                           1,326,000
Amended N 2019 Equity Compensation Plan [Member]                            
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]                            
Number of Shares Authorized                       4,600,000 2,500,000